Ulcerative colitis trials in China

In China 67 Also abroad 382

67 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC
Where
Guangzhou
Age
18 years to 75 years
People
288
Run by
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
See details and how to joinNCT07507513
No phaseEnrolling by invitation
Predictive Efficacy of Fecal Calprotectin Assay by Magnetic Particle Chemiluminescence for Mucosal Healing in Moderate-to-Severe Ulcerative Colitis Patients Undergoing Initial Biologic Therapy（PRECAL）
Where
Beijing, Chongqing, Dalian, Nanjing, Qingdao, Shengyang, Shenzhen, Wuhan, Xi'an
Age
18 years and over
People
200
Run by
Tang-Du Hospital
See details and how to joinNCT07721441
No phaseNot yet taking people in China
A National Multicenter Study of Etrasimod for the Treatment of Patients With Active UC
Where
Xi'an
Age
18 years and over
People
500
Run by
Tang-Du Hospital
See details and how to joinNCT07705126
No phaseTaking people
Fecal Microbiota Transplantation in Pediatric Ulcerative Colitis (UC)
Where
Wuhan
Age
2 years to 16 years
People
30
Run by
Biao Zou
See details and how to joinNCT05679622
Phase 1/2Taking people
A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative Colitis
Where
Beijing, Guangzhou, Hangzhou, Shanghai, Shenyang, Taiyuan, Weifang, Wenzhou, Wuhan, Xi'an, Xinxiang
Age
18 years to 75 years
People
24
Run by
Innatus Therapeutics (Shanghai) Co., Ltd.
See details and how to joinNCT07692165
No phaseTaking people
IBD Biomarker Discovery and Validation Platform
Where
Guangzhou
Age
14 years and over
People
6,000
Run by
Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT07686406
Phase 3Not yet taking people in China
Hemay005 for the Treatment of Chinese Moderately to Severely Active Ulcerative Colitis
Where
Guangzhou
Age
18 years to 80 years
People
360
Run by
Ganzhou Hemay Pharmaceutical Co., Ltd
See details and how to joinNCT07650942
Phase 4Taking people
Comparative Effectiveness of Upadacitinib vs Corticosteroids as First-Line Therapy for Acute Severe Ulcerative Colitis（UPFRONT）
Where
Ankang, Hanzhong, Xi'an, Xianyang
Age
18 years to 85 years
People
46
Run by
Yongquan Shi
See details and how to joinNCT07546097
Phase 2Taking people
A Phase 2 Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of HRS-7085 Tablets in Patients With Inflammatory Bowel Disease
Where
Chengdu
Age
18 years to 75 years
People
48
Run by
Shandong Suncadia Medicine Co., Ltd.
See details and how to joinNCT07229950
Phase 2Taking people
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Where
Chongqing, Guangdong, Guangzhou, Shanghai
Age
18 years to 75 years
People
192 worldwide
Run by
Takeda
See details and how to joinNCT06764615 · EU 2024-518914-18-00
Phase 1Taking people
Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease
Where
Bengbu, Changchun, Changsha, Guangzhou, Harbin, Hengyang, Huizhou, Kunming, Luoyang, Luzhou, Meihekou, Nanjing, Nanyang, Shanghai, Shenyang, Taishan, Taiyuan, Taizhou, Tianjin, Ürümqi, Wuhan, Wuwei, Zhengzhou
Age
18 years to 75 years
People
135
Run by
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
See details and how to joinNCT06754891
Phase 3Taking people
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Where
Beijing, Changsha, Hangzhou, Shanghai, Zhengzhou
Age
2 years to 17 years
People
240 worldwide
Run by
Takeda
See details and how to joinNCT05442567 · EU 2023-509046-36-00
No phaseTaking people
Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis
Where
Guangzhou
Age
18 years and over
People
334
Run by
Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT06095596
Phase 4Taking people
Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety
Where
Guangzhou
Age
18 years to 65 years
People
200
Run by
Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT07216014
Phase 4Taking people
Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative Colitis（UPRISE）
Where
Ankang, Hanzhong, Xi'an, Xianyang
Age
18 years to 85 years
People
226
Run by
Xijing Hospital of Digestive Diseases
See details and how to joinNCT07550673
Phase 1/2Not yet taking people in China
BCMA-CD19 cCAR T for the Treatment of Refractory Inflammatory Bowel Disease (IBD)
Where
Zhongshan
Age
18 years to 70 years
People
18
Run by
iCell Gene Therapeutics
See details and how to joinNCT07544160
Phase 2Not yet taking people in China
Efficacy and Safety of IPG11406 in Moderately to Severely Active Ulcerative Colitis (Phase 2)
Where
Beijing
Age
18 years to 70 years
People
144
Run by
Nanjing Immunophage Biotech Co., Ltd
See details and how to joinNCT07535489
No phaseTaking people
A Prospective Observational Study on the Efficacy and Safety of Guselkumab in the Treatment of Crohn's Disease Patients Previously Treated With Ustekinumab
Where
Hangzhou
Age
18 years to 75 years
People
60
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07487480
Phase 2Taking people
A Study for HSK47388 in Participants With Ulcerative Colitis
Where
Hangzhou
Age
18 years to 75 years
People
150
Run by
Haisco Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07335055
Early phase 1Taking people
Autologous CAR-T Cell Therapy for Refractory and Relapsing Ulcerative Colitis: A Single-Center Exploratory Study
Where
Guangzhou
Age
18 years to 60 years
People
12
Run by
Hebei Senlang Biotechnology Inc., Ltd.
See details and how to joinNCT07435779
No phaseTaking people
Prophylactic Dexamethasone Before Infliximab in Moderate-to-Severe IBD
Where
Hangzhou
Age
14 years to 80 years
People
300
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07385131
Early phase 1Not yet taking people in China
A Study of Cizutamig for Patients With Ulcerative Colitis
Where
Shanghai
Age
18 years to 75 years
People
15
Run by
Ruijin Hospital
See details and how to joinNCT07353450
No phaseTaking people
Clinical Characteristics of Sleep Disorders in Patients With Ulcerative Colitis
Where
Xi'an
Age
18 years to 65 years
People
152
Run by
Xijing Hospital
See details and how to joinNCT06359808
Early phase 1Not yet taking people in China
Universal CAR-T Cell Injection Targeting CD19/BCMA in Patients With Inflammatory Bowel Disease
Where
Wuhan
Age
18 years to 70 years
People
30
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07309744
No phaseTaking people
Exploratory Clinical Trial of Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis.
Where
Xi'an
Age
18 years and over
People
15
Run by
Xijing Hospital
See details and how to joinNCT05895981